Lyme Disease Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Lyme Disease Tests Market Overview

The Lyme disease tests market size was valued at $11.3 million in 2023. The Lyme disease tests market will grow at a CAGR of more than 6% from 2023 to 2033. The tests help to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint disease.

Lyme Disease Tests Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights on the Lyme Disease Tests Market Forecast, Download a Free Sample Report

The Lyme disease tests market research report identifies quantitative market trends within in vitro diagnostics therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the Lyme disease tests market for 2020 and beyond. Furthermore, the report also provides Lyme disease tests market share by company that will help in identifying untapped market opportunities.

Lyme Disease Tests Market Segments

The key segments in the Lyme disease tests market are Lyme disease enzyme immunoassay tests, Lyme disease other tests, and Lyme disease western blot tests. In 2023, the Lyme disease enzyme immunoassay tests segment dominated the market share.

Lyme disease EIA tests employ the Enzyme Linked Immunosorbent Assay (ELISA) technique to screen for Lyme disease. ELISA test is one of the most widely used in biomedical research for both scientific and diagnostic purposes. It measures the level of antibodies i.e., IgG or IgM against Lyme bacteria.

Lyme disease western blot tests identify Lyme disease antibodies and are used as a confirmatory test following a positive ELISA test. Lyme disease western blot tests are used to detect a chronic Lyme disease infection. This test also detects antibodies; however, it reports the reactivity against different types of protein found in Lyme-causing bacteria. The western blot test is carried out for all positive or equivocal results following an ELISA test.

Lyme Disease Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights into the Lyme Disease Tests Market, Download a Free Sample Report

Regional Analysis of Lyme Disease Tests Market

The key regions in the Lyme disease tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. European Lyme disease tests market had the highest share in 2023 owing to high cases of Lyme disease. The number of cases is increasing steadily with more than 360,000 cases reported over the last two decades. Central Europe is the region with the highest number of Lyme disease cases mostly in countries such as the Czech Republic, Estonia, Lithuania, and Slovenia.

Lyme Disease Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Lyme Disease Tests Market, Download A Free Sample Report

Lyme Disease Tests Market – Competitive Landscape

In 2023, bioMerieux Lyme disease tests market share was the highest

The key companies in the Lyme disease tests market are:

• bioMerieux SA
• EUROIMMUN US LLC + Oxford Immunotec Ltd
• Meridian Bioscience Inc
• Thermo Fisher Scientific Inc
• DiaSorin SpA

Many top companies are planning to invest in R&D to improve diagnosis, false positives, and false negative results of ELISA and Western blot tests. Companies aim to maintain low prices and meet efficacy targets.

Lyme Disease Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Lyme Disease Tests Market, Download a Free Sample Report

Lyme Disease Tests Market Dynamics

Trends: The incidence of Lyme disease is expected to increase in many countries during the forecast period, across all geographical regions. The regions expected to witness a rise in the incidence rate of the condition are the US, Canada, France, and South Korea among others. The primary reasons for the rise in Lyme disease cases are population growth and lack of public awareness.

Future Outlook: Global Data expects that the market growth for Lyme disease tests will be strongest in North America and Europe. If left untreated, Lyme disease can further lead to nervous system and immune system disorders. Thus, investments will be directed towards the development of new techniques and tests by the governments in the coming years.

Buy the Full Report for Additional Lyme Disease Tests Market Dynamics, Download a Free Sample Report

Segments Covered in this Report.

Lyme Disease Tests Segment Outlook ($ Million, 2015-2033)

• Lyme Disease Enzyme Immunoassay Tests
• Lyme Disease Other Tests
• Lyme Disease Western Blot Tests

Lyme Disease Tests Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

The Lyme disease tests market research report includes an insightful review of the key industry trends.

• The Lyme disease tests market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
• The report also includes market-level data on units, average selling prices, and market values.

Regional, country, and global Lyme disease tests market insights:

• The Lyme disease tests market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• Lyme disease tests market SWOT analysis.
• The report provides trends and Lyme disease tests market competitive dynamics.

Buy the Full Report for More Insights into the Lyme Disease Tests Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies covered: Thermo Fisher Scientific Inc, Revvity Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Qiagen NV, Meridian Bioscience Inc, Trinity Biotech Plc, DiaSorin SpA, Quidelortho Corp, ERBA Diagnostics Inc, ZEUS Scientific Inc, Viramed Biotech AG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

• Extensive coverage of the Lyme disease tests market under development.
• An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
• Reviews of major players involved in the development of the Lyme disease tests market and lists all their pipeline projects.
• Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
• Key clinical trial data of ongoing clinical trials specific to pipeline products.
• Recent developments in the segment/industry.

Reasons to Buy

• Understand the COVID-19 impact on Lyme disease tests.
• Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Lyme disease tests.
• Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
• Formulate effective sales and marketing strategies with a detailed evaluation of Lyme disease tests market share by company. Identify strong competitors and create winning strategies to stand out in the global Lyme disease tests market.
• Track regional Lyme disease tests market sales as well as country-specific transactions from 2015-2033.
• Organize your sales and marketing efforts by identifying the global Lyme disease tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.